Syed Fawad Hussain Shah
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $535.83 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $144.59 | 2 | $0 (2024) |
| PFIZER INC. | $79.17 | 4 | $0 (2024) |
| ABBVIE INC. | $63.84 | 3 | $0 (2024) |
| Lilly USA, LLC | $44.34 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $37.63 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $31.82 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $29.24 | 1 | $0 (2024) |
| SK Life Science, Inc. | $24.31 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $21.95 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $21.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.25 | 15 | Eisai Inc. ($144.59) |
| 2023 | $113.58 | 6 | SK Life Science, Inc. ($24.31) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Rare Disease | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Neurology | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Neuroscience | ||||||
| 07/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: PAIN | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: PAIN | ||||||
| 04/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Cardio-renal | ||||||
| 10/24/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neuroscience | ||||||
| 04/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.31 | General |
| 03/28/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 162 | 194 | $58,972 | $20,034 |
| 2022 | 5 | 180 | 208 | $89,371 | $19,657 |
| 2021 | 1 | 15 | 15 | $4,875 | $2,344 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 55 | $21,133 | $7,302 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 63 | $12,998 | $5,738 | 44.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 23 | $10,040 | $3,749 | 37.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,948 | $1,524 | 38.6% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 22 | 26 | $7,804 | $1,122 | 14.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 15 | 15 | $3,049 | $600.32 | 19.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 61 | $19,825 | $8,890 | 44.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 72 | $16,200 | $5,545 | 34.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 17 | $7,412 | $2,685 | 36.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 32 | 36 | $28,224 | $1,553 | 5.5% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 22 | 22 | $17,710 | $984.94 | 5.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $4,875 | $2,344 | 48.1% |
About Syed Fawad Hussain Shah
Syed Fawad Hussain Shah is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1255863627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Syed Fawad Hussain Shah has received a total of $535.83 in payments from pharmaceutical and medical device companies, with $422.25 received in 2024. These payments were reported across 21 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($535.83).
As a Medicare-enrolled provider, Shah has provided services to 357 Medicare beneficiaries, totaling 417 services with total Medicare billing of $42,036. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Syracuse, NY
- Active Since 04/03/2017
- Last Updated 04/04/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1255863627
Products in Payments
- Leqembi (Drug) $144.59
- NURTEC ODT (Drug) $61.12
- EMGALITY (Drug) $44.34
- REXULTI (Drug) $37.63
- BOTOX (Biological) $30.91
- ULTOMIRIS (Biological) $29.24
- INGREZZA (Drug) $21.95
- Kerendia (Drug) $21.84
- Repatha (Biological) $19.26
- ELIQUIS (Drug) $18.05
- BELSOMRA (Drug) $17.84
- QULIPTA (Drug) $17.21
- AJOVY (Biological) $16.70
- UBRELVY (Drug) $15.72
- Austedo XR (Drug) $15.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144